|
GB8730011D0
(en)
*
|
1987-12-23 |
1988-02-03 |
Smithkline Dauelsberg |
Pharmaceutical compositions
|
|
US5096716A
(en)
*
|
1988-09-01 |
1992-03-17 |
Alza Corporation |
Dosage form for administering calcium antagonist nicardipine
|
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
|
US5186942A
(en)
*
|
1989-01-30 |
1993-02-16 |
Alza Corporation |
Nicardipine therapy
|
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
|
DE4101873C2
(de)
*
|
1991-01-23 |
1993-12-09 |
Isis Pharma Gmbh |
Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
|
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
|
DK0746356T3
(da)
*
|
1991-10-24 |
2000-10-02 |
Macromed Inc |
Gasdrevet anordning til indgivelse af medikamenter
|
|
US5246710A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating cyclothymia
|
|
US5185158A
(en)
*
|
1992-02-27 |
1993-02-09 |
Alza Corporation |
Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
|
|
US5858407A
(en)
*
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
|
US5246711A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating dysthymia
|
|
US5688518A
(en)
*
|
1992-02-27 |
1997-11-18 |
Alza Corporation |
Antidepressive therapy
|
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
|
US5462741A
(en)
*
|
1992-08-06 |
1995-10-31 |
Alza Corporation |
High agent loaded controlled release dispenser
|
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
|
US6919373B1
(en)
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
|
US6203813B1
(en)
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
|
US5951538A
(en)
*
|
1997-08-07 |
1999-09-14 |
Ceramatec, Inc. |
Gas generating device for delivering beneficial agents to a body cavity
|
|
US6645192B2
(en)
*
|
1998-09-30 |
2003-11-11 |
Ivy Animal Health, Inc. |
Pellet implant system for immediate and delayed release of antiparasitic drug
|
|
US6706282B1
(en)
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
|
IL142807A0
(en)
*
|
1998-11-02 |
2002-03-10 |
Alza Corp |
Controlled delivery of active agents
|
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
|
US6491683B1
(en)
|
1999-09-07 |
2002-12-10 |
Alza Corporation |
Osmotic dosage form composed of an extruded polymer tube form
|
|
DE60018606T2
(de)
*
|
1999-12-16 |
2005-07-28 |
Alza Corp., Mountain View |
Dosierungsformen mit einer Barriereschicht gegen Laserablation
|
|
WO2003092648A1
(en)
*
|
2002-04-29 |
2003-11-13 |
Alza Corporation |
Methods and dosage forms for controlled delivery of oxycodone
|
|
CA2487786A1
(en)
*
|
2002-05-31 |
2003-12-11 |
Alza Corporation |
Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
|
CA2494233A1
(en)
*
|
2002-07-29 |
2004-02-05 |
Alza Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
JP2006522016A
(ja)
*
|
2003-01-14 |
2006-09-28 |
アルザ・コーポレーシヨン |
改変された粘度の層を用いる方法および投薬形態物
|
|
US20040197407A1
(en)
*
|
2003-02-11 |
2004-10-07 |
Ramkumar Subramanian |
Methods and dosage forms with modified layer geometry
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
DE102005005446A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
EP1658054B1
(de)
*
|
2003-08-06 |
2007-06-27 |
Grünenthal GmbH |
Gegen missbrauch gesicherte darreichungsform
|
|
US20070048228A1
(en)
*
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
US20050058707A1
(en)
*
|
2003-08-06 |
2005-03-17 |
Iran Reyes |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
|
US8075872B2
(en)
*
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
DE102004032051A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
MXPA06002067A
(es)
*
|
2003-08-22 |
2006-08-11 |
Johnson & Johnson |
Suministro gradual de topiramato durante periodo prolongado.
|
|
CN102697704A
(zh)
*
|
2003-09-26 |
2012-10-03 |
阿尔扎公司 |
阿片类与非阿片类镇痛药的控释制剂
|
|
MXPA06003451A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Formas de dosificacion osmotica para suministro controlado de alprazolam.
|
|
CA2540308C
(en)
|
2003-09-26 |
2013-08-06 |
Alza Corporation |
Drug coating providing high drug loading and methods for providing the same
|
|
MXPA06003453A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Barra de empuje oros para el suministro controlado de agentes activos.
|
|
US20050169992A1
(en)
*
|
2003-12-23 |
2005-08-04 |
Frank Jao |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
|
EP1701706A2
(en)
*
|
2003-12-29 |
2006-09-20 |
Alza Corporation |
Novel drug compositions and dosage forms
|
|
MXPA06007510A
(es)
*
|
2003-12-29 |
2009-06-10 |
Johnson & Johnson |
Composiciones de farmaco y formas de dosis novedosas de topiramato.
|
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
DE102004032049A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
WO2006023286A2
(en)
*
|
2004-08-19 |
2006-03-02 |
Alza Corporation |
Controlled release nanoparticle active agent formulation dosage forms and methods
|
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
DE102005005449A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
US7959938B2
(en)
*
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
|
US8778395B2
(en)
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
|
EP1933811A2
(en)
*
|
2005-09-30 |
2008-06-25 |
Alza Corporation |
Banded controlled release nanoparticle active agent formulation dosage forms and methods
|
|
AU2006334020B2
(en)
*
|
2005-12-30 |
2012-07-05 |
Mor Research Applications Ltd. |
Device and method for treating the anal sphincter
|
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US9011930B2
(en)
*
|
2006-05-01 |
2015-04-21 |
Zycal Bioceuticals Healthcare Company, Inc. |
Nutritional supplement and use thereof
|
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
|
EP2359808B1
(en)
|
2006-08-09 |
2013-05-22 |
Intarcia Therapeutics, Inc |
Osmotic delivery systems and piston assemblies
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
US7538652B2
(en)
*
|
2006-08-29 |
2009-05-26 |
International Business Machines Corporation |
Electrical component tuned by conductive layer deletion
|
|
DE102007011485A1
(de)
*
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
WO2008133908A2
(en)
|
2007-04-23 |
2008-11-06 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
CA2713128C
(en)
|
2008-01-25 |
2016-04-05 |
Gruenenthal Gmbh |
Pharmaceutical dosage form
|
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
AU2009243681B2
(en)
*
|
2008-05-09 |
2013-12-19 |
Grunenthal Gmbh |
Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
|
|
EP2445481B1
(en)
|
2009-06-18 |
2017-03-22 |
Rdd Pharma Ltd. |
Methods and devices for delivery of pharmaceutical agents within orifices of the body
|
|
CN102639118B
(zh)
|
2009-07-22 |
2015-07-29 |
格吕伦塔尔有限公司 |
氧化稳定的抗干扰剂型
|
|
KR101738369B1
(ko)
|
2009-07-22 |
2017-05-22 |
그뤼넨탈 게엠베하 |
핫 멜트 압출된 제어 방출 투여형
|
|
US9053844B2
(en)
*
|
2009-09-09 |
2015-06-09 |
Littelfuse, Inc. |
Geometric configuration or alignment of protective material in a gap structure for electrical devices
|
|
RU2547990C2
(ru)
|
2009-09-28 |
2015-04-10 |
Интарсия Терапьютикс, Инк. |
Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
|
|
ES2606227T3
(es)
*
|
2010-02-03 |
2017-03-23 |
Grünenthal GmbH |
Preparación de una composición farmacéutica en polvo mediante una extrusora
|
|
TWI516286B
(zh)
|
2010-09-02 |
2016-01-11 |
歌林達股份有限公司 |
含陰離子聚合物之抗破碎劑型
|
|
BR112013005194A2
(pt)
|
2010-09-02 |
2016-05-03 |
Gruenenthal Gmbh |
forma de dosagem resistente à violação compreendendo sal inorgânico
|
|
US9000046B2
(en)
|
2010-09-28 |
2015-04-07 |
Depomed, Inc. |
Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
BR112014001091A2
(pt)
|
2011-07-29 |
2017-02-14 |
Gruenenthal Gmbh |
comprimido resistente à adulteração que fornece liberação imediata do fármaco
|
|
EA201400172A1
(ru)
|
2011-07-29 |
2014-06-30 |
Грюненталь Гмбх |
Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
|
|
MX356421B
(es)
|
2012-02-28 |
2018-05-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
|
|
EP2838512B1
(en)
|
2012-04-18 |
2018-08-22 |
Grünenthal GmbH |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
US20140088345A1
(en)
*
|
2012-09-27 |
2014-03-27 |
Palo Alto Research Center Incorporated |
Single channel, multiple drug delivery device and methods
|
|
US9737490B2
(en)
|
2013-05-29 |
2017-08-22 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile
|
|
EP3003279A1
(en)
|
2013-05-29 |
2016-04-13 |
Grünenthal GmbH |
Tamper-resistant dosage form containing one or more particles
|
|
BR112016000194A8
(pt)
|
2013-07-12 |
2019-12-31 |
Gruenenthal Gmbh |
forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
|
|
EP3073994A1
(en)
|
2013-11-26 |
2016-10-05 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
|
US20160310408A1
(en)
*
|
2013-12-06 |
2016-10-27 |
Durect Corporation |
Compositions Comprising Antioxidant, Fluid Dispensers, and Methods Involving the Same
|
|
US9297083B2
(en)
|
2013-12-16 |
2016-03-29 |
Palo Alto Research Center Incorporated |
Electrolytic gas generating devices, actuators, and methods
|
|
WO2015173195A1
(en)
|
2014-05-12 |
2015-11-19 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
|
EA201692388A1
(ru)
|
2014-05-26 |
2017-05-31 |
Грюненталь Гмбх |
Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
|
|
US9801660B2
(en)
|
2014-07-31 |
2017-10-31 |
Palo Alto Research Center Incorporated |
Implantable fluid delivery devices, systems, and methods
|
|
US10278675B2
(en)
|
2014-07-31 |
2019-05-07 |
Palo Alto Research Center Incorporated |
Implantable estrus detection devices, systems, and methods
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
WO2016170097A1
(en)
|
2015-04-24 |
2016-10-27 |
Grünenthal GmbH |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
|
RU2730996C2
(ru)
|
2015-06-03 |
2020-08-26 |
Интарсия Терапьютикс, Инк. |
Системы установки и извлечения имплантата
|
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
|
KR102574993B1
(ko)
|
2016-05-16 |
2023-09-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
JP7286542B2
(ja)
|
2017-01-03 |
2023-06-05 |
インターシア セラピューティクス,インコーポレイティド |
Glp-1受容体アゴニストの持続的投与及び薬物の同時投与を含む方法
|
|
US9707217B1
(en)
|
2017-02-03 |
2017-07-18 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dose-dumping resistant controlled release dosage form
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
HUE067496T2
(hu)
|
2020-12-08 |
2024-10-28 |
Ruminant Biotech Corp Ltd |
Az állatoknak szánt anyagok bejuttatására szolgáló eszközök és módszerek fejlesztése
|